Our results suggest that cancer-related fatigue predicts depression, especially in participants with the BDNF Met/Met genotype, and the relationship between the BDNF polymorphism and depression appears to be mediated by cancer-related fatigue in our population of female cancer survivors. Here, BDNF is linked to depressive disorder.